Frankfurt - Delayed Quote EUR
Adverum Biotechnologies, Inc. (AVU0.F)
2.5200
-0.0600
(-2.33%)
At close: 8:26:00 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-92,462
-92,462
-90,902
-108,091
-107,831
Investing Cash Flow
-41,889
-41,889
96,875
141,720
78,709
Financing Cash Flow
120,003
120,003
69
607
2,397
End Cash Position
62,628
62,628
76,976
70,934
36,698
Capital Expenditure
-388
-388
-808
-11,816
-15,123
Issuance of Capital Stock
119,361
119,361
--
--
1,685
Repayment of Debt
--
--
--
--
-240
Free Cash Flow
-92,850
-92,850
-91,710
-119,907
-122,954
12/31/2021 - 8/5/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1JK.F Apellis Pharmaceuticals, Inc.
14.60
-1.43%
1T3.F Syndax Pharmaceuticals, Inc.
11.40
-0.87%
F6T.F Fate Therapeutics, Inc.
1.0990
-6.19%
THRD Third Harmonic Bio, Inc.
5.15
+0.19%
SION Sionna Therapeutics, Inc.
12.04
-0.82%
FULC Fulcrum Therapeutics, Inc.
3.5700
+1.13%
TENX Tenax Therapeutics, Inc.
5.87
+1.32%
KYTX Kyverna Therapeutics, Inc.
2.0500
-2.38%
NGNE Neurogene Inc.
14.50
-5.91%
SNDX Syndax Pharmaceuticals, Inc.
13.42
+0.68%